Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Depression

Free Subscription Articles published in Can J Psychiatry Retrieve available abstracts of 44 articles: HTML format

Single Articles

November 2025
1. MACRYNIKOLA N, Chang S, Torous J
   Emotion Regulation Self-Efficacy as a Mechanism of Alliance and Outcomes in a Brief, Transdiagnostic Digital Mental Health Intervention: L'auto-efficacite de la regulation des emotions en tant que mecanisme d'alliance et de resultats dans une breve in
   Can J Psychiatry. 2025;70:824-833.
   PubMed     Abstract available
   
   
   October 2025
2. CHISAMORE N, Kaczmarek ES, Doyle Z, Johnson DE, et al
   Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidepresseurs de la psychoth
   Can J Psychiatry. 2025;70:759-767.
   PubMed     Abstract available
   
   
   
3. DEMAYO MM, Cole J, Sohn MN, Bray SL, et al
   Procognitive Effects of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation in Major Depressive Disorder: Effets procognitifs de la D-cycloserine en traitement complementaire par la stimulation theta-burst intermittente dans le trouble de
   Can J Psychiatry. 2025;70:750-758.
   PubMed     Abstract available
   
   
   September 2025
4. BAHJI A, Tang V, Danilewitz M
   Integrated Management of Co-Occurring Alcohol Use Disorder and Depression: Clinical Approaches for Concurrent Disorders.
   Can J Psychiatry. 2025 Sep 3:7067437251374564. doi: 10.1177/07067437251374564.
   PubMed     Abstract available
   
   
   August 2025
5. MESHKAT S, Lin Q, Tassone VK, Janssen-Aguilar R, et al
   Mental Health Service Type Use and Depressive Symptoms: A Multivariable Analysis of Sociodemographic Correlates: Utilisation des services de sante mentale et symptomes depressifs : Analyse multi-variables des correlats sociodemographiques.
   Can J Psychiatry. 2025;70:611-619.
   PubMed     Abstract available
   
   
   July 2025
6. MAGARBEH L, Elsheikh SSM, Islam F, Marshe VS, et al
   Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des resultats du traitement antidepresseur a l'aide des scores de risque polygeniques : Rapport sur l'etude CAN-BIND-1.
   Can J Psychiatry. 2025;70:552-564.
   PubMed     Abstract available
   
   
   
7. ABU-ASHOUR W, Delaney S, Farrell A, Gamble JM, et al
   Incidence of Major Depressive Disorder Relapse and Effectiveness of Pharmacologic and Psychological Interventions in Primary Care: A Systematic Review and Meta-Analysis: Incidence de la rechute du trouble depressif majeur et efficacite des interventio
   Can J Psychiatry. 2025;70:529-551.
   PubMed     Abstract available
   
   
   May 2025
8. NG E, Nestor SM, Rabin JS, Hamani C, et al
   Impact of Comorbid Posttraumatic Stress-Related Symptoms on Repetitive Transcranial Magnetic Stimulation for Depression in Civilians: Incidence des symptomes du trouble de stress post-traumatique (TSPT) comorbide sur la stimulation magnetique transcra
   Can J Psychiatry. 2025 May 30:7067437251342277. doi: 10.1177/07067437251342277.
   PubMed     Abstract available
   
   
   
9. ASADULLAH H, Abbasi SUAM, Nabi R
   Integrating Mental Health in Perioperative Care: Addressing the Overlooked Impact of Chronic Stress and Depression on Surgical Outcomes.
   Can J Psychiatry. 2025 May 19:7067437251340667. doi: 10.1177/07067437251340667.
   PubMed    
   
   
   
10. NAEEM F, Husain MI, Husain MO, Mutta B, et al
    Feasibility and Acceptability of Online Culturally Adapted Cognitive Behavioural Therapy for Depression and Anxiety in Canadians of South Asian Origin: A Randomized Controlled Trial: Faisabilite et acceptabilite de la therapie cognitivo-comportemental
    Can J Psychiatry. 2025 May 15:7067437251337644. doi: 10.1177/07067437251337644.
    PubMed     Abstract available
    
    
    
11. LONGMORE A, Anagnostou E, Georgiages S, Jones J, et al
    Predictors of Depressive Symptoms in Autistic Youth-A Longitudinal Study From the Province of Ontario Neurodevelopmental Disorders (POND) Network: Predicteurs des symptomes depressifs chez les jeunes autistes-une etude longitudinale du Reseau des trou
    Can J Psychiatry. 2025;70:372-381.
    PubMed     Abstract available
    
    
    April 2025
12. LAM RW, Rnic K, Nunez JJ, Ho K, et al
    Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Predire la rechute d'episodes depressifs pendant le tra
    Can J Psychiatry. 2025 Apr 29:7067437251337603. doi: 10.1177/07067437251337603.
    PubMed     Abstract available
    
    
    
13. PIAUX C, Bourquin C, Stiefel F
    Depressive Symptoms and Epistemological Approaches: A Qualitative Study Among Psychiatrists: Symptomes depressifs et approches epistemologiques : une etude qualitative aupres de psychiatres.
    Can J Psychiatry. 2025;70:320-327.
    PubMed     Abstract available
    
    
    March 2025
14. DAMA MH, Martin J, Tassone VK, Lin Q, et al
    The Association Between Delayed Sleep-Wake Phase Disorder and Depression Among Young Individuals: A Systematic Review and Meta-Analysis: Association entre le syndrome de retard de phase et la depression parmi les jeunes : revue systematique et meta-an
    Can J Psychiatry. 2025 Mar 24:7067437251328308. doi: 10.1177/07067437251328308.
    PubMed     Abstract available
    
    
    
15. CHINNA MEYYAPPAN A, Sgarbossa C, Bromley H, Forth E, et al
    The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression - A Phase 2, Double-Blind, Placebo-Controlled Study: Clinical Results: Innocuite et efficacite du traitement de l'ecosysteme microbien (met-2) dans la depress
    Can J Psychiatry. 2025 Mar 21:7067437251328270. doi: 10.1177/07067437251328270.
    PubMed     Abstract available
    
    
    
16. RAE J, Lavigne KM, Sauve G, Lepage M, et al
    Mapping Insight Dimensions and Symptom Dynamics in Schizophrenia: A Data-Driven Network Approach: Cartographie des dimensions d'insight et de la dynamique symptomatique dans la schizophrenie: une approche par reseau fondee sur les donnees.
    Can J Psychiatry. 2025 Mar 21:7067437251329074. doi: 10.1177/07067437251329074.
    PubMed     Abstract available
    
    
    
17. OSTINELLI EG, Jaquiery M, Liu Q, Elgarf R, et al
    Personalising Antidepressant Treatment for Unipolar Depression Combining Individual Choices, Risks and big Data: The PETRUSHKA Tool: Personnalisation du traitement antidepresseur de la depression unipolaire associant choix individuels, risques et mega
    Can J Psychiatry. 2025 Mar 13:7067437251322399. doi: 10.1177/07067437251322399.
    PubMed     Abstract available
    
    
    January 2025
18. GOKE K, McClintock SM, Mah L, Rajji TK, et al
    Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Resultats cognitifs apres la stimulation magnetique transcranienne pour le traitement de la depression chez les personnes agees.
    Can J Psychiatry. 2025 Jan 29:7067437251315515. doi: 10.1177/07067437251315515.
    PubMed     Abstract available
    
    
    December 2024
19. MARCHETTI S, Feinstein A
    The Psychological Health of Iranian Citizens Protesting the Actions of Their Country's Morality Police: La sante psychologique des citoyens iraniens qui manifestent contre les actions de la police des moeurs de leur pays.
    Can J Psychiatry. 2024;69:861-868.
    PubMed     Abstract available
    
    
    November 2024
20. ABBASS A, Luyten P, Leichsenring F
    Short-Term Psychodynamic Psychotherapy is the First-Line Option for Depression and Treatment Resistant Depression According to Available Evidence.
    Can J Psychiatry. 2024 Nov 18:7067437241299487. doi: 10.1177/07067437241299487.
    PubMed    
    
    
    October 2024
21. MAN LLY, Rotenberg M, Andari S, Wells S, et al
    Eco-Depression and Eco-Anxiety Among Youth: A Sex and Gender Analysis.
    Can J Psychiatry. 2024 Oct 1:7067437241287153. doi: 10.1177/07067437241287153.
    PubMed    
    
    
    September 2024
22. BECK K, Young AH
    Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults - Capturing the State of the Art.
    Can J Psychiatry. 2024;69:692-694.
    PubMed    
    
    
    
23. LAM RW, Kennedy SH, Adams C, Bahji A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Reseau canadien pour les traitements de l'humeur et de l'anxiete (CANMAT) 2023 : Mise a jour des lignes
    Can J Psychiatry. 2024;69:641-687.
    PubMed     Abstract available
    
    
    July 2024
24. THERRIEN F, Ward C, Chokka P, Habert J, et al
    Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble depressif majeur: une etu
    Can J Psychiatry. 2024;69:513-523.
    PubMed     Abstract available
    
    
    
25. MOINUL D, Hao C, Dimitropoulos G, Taylor VH, et al
    Patient Perceptions of Microbiome-Based Therapies as Novel Treatments for Mood Disorders: A Mixed Methods Study: Perceptions des patients sur les therapies basees sur le microbiome pour les troubles de l'humeur : une etude a methodes mixtes.
    Can J Psychiatry. 2024;69:503-512.
    PubMed     Abstract available
    
    
    June 2024
26. CHEN Y, Zhao J, Wang J, Peng L, et al
    Effect of Bright Light Therapy on Perinatal Depression: A Systematic Review and Meta-Analysis: Effet de la luminotherapie sur la depression perinatale: une revue systematique et une meta-analyse.
    Can J Psychiatry. 2024 Jun 11:7067437241248051. doi: 10.1177/07067437241248051.
    PubMed     Abstract available
    
    
    May 2024
27. WONG M, Kiss A, Herrmann N, Lanctot KL, et al
    Modifiable Risk Factors Associated With Cognitive Decline in Late Life Depression: Findings From the Canadian Longitudinal Study on Aging: Facteurs de risque modifiables associes au declin cognitif dans la depression en fin de vie : constatations de l
    Can J Psychiatry. 2024 May 15:7067437241255095. doi: 10.1177/07067437241255095.
    PubMed     Abstract available
    
    
    April 2024
28. SCHELL C, Quilty LC, Cunningham JA
    Investigating Alexithymia as a Moderator of Outcomes in a Randomized Controlled Trial of an Online Intervention for Co-Occurring Depression and Hazardous Alcohol Use: Enquete sur l'alexithymie en tant que moderateur des resultats dans un essai randomi
    Can J Psychiatry. 2024 Apr 29:7067437241249412. doi: 10.1177/07067437241249412.
    PubMed     Abstract available
    
    
    
29. BERK M, Agustini B, Forbes M, Jacka FN, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression Treatment.
    Can J Psychiatry. 2024 Apr 22:7067437241248087. doi: 10.1177/07067437241248087.
    PubMed    
    
    
    
30. LI VW, Sahota J, Dev DK, Gill DD, et al
    A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une evaluation randomisee de MoodFX, un outil de sante en ligne centre sur le patient pour soutenir la mesure du resultat dans la depress
    Can J Psychiatry. 2024 Apr 11:7067437241245331. doi: 10.1177/07067437241245331.
    PubMed     Abstract available
    
    
    
31. WANG T, Gao C, Li J, Li L, et al
    Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and P11 Gene DNA Methylation: Prediction de l'efficacite precoce d'un antidepresseur chez des patients souffrant du tr
    Can J Psychiatry. 2024;69:264-274.
    PubMed     Abstract available
    
    
    February 2024
32. JALALI S, Liu L, Wang J, Kennedy SH, et al
    Factors Associated with Transition to Serious Mental Illness.
    Can J Psychiatry. 2024;69:79-88.
    PubMed     Abstract available
    
    
    
33. LAPOSA JM, Cameron D, Corace K, Quick N, et al
    A Rapid Access Brief Psychotherapy Intervention to Respond to Healthcare Workers in Ontario Whose Mental Health was Negatively Impacted During the COVID-19 Pandemic.
    Can J Psychiatry. 2024;69:89-99.
    PubMed     Abstract available
    
    
    December 2023
34. LAI KSP, Waxman R, Blumberger DM, Giacobbe P, et al
    Competencies for Repetitive Transcranial Magnetic Stimulation in Postgraduate Medical Education: Expert Consensus Using a Modified Delphi Process.
    Can J Psychiatry. 2023;68:916-924.
    PubMed     Abstract available
    
    
    November 2023
35. KHAN I, Chawla N
    Comments on "A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial".
    Can J Psychiatry. 2023 Nov 22:7067437231216175. doi: 10.1177/07067437231216175.
    PubMed    
    
    
    
36. PINTO JV, Crippa JAS, Cereser KM, Vianna-Sulzbach MF, et al
    Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study.
    Can J Psychiatry. 2023 Nov 3:7067437231209650. doi: 10.1177/07067437231209650.
    PubMed     Abstract available
    
    
    October 2023
37. ISLAM F, Magarbeh L, Elsheikh SSM, Kloiber S, et al
    Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.
    Can J Psychiatry. 2023 Oct 5:7067437231203433. doi: 10.1177/07067437231203433.
    PubMed     Abstract available
    
    
    September 2023
38. ANDREWS KL, Jamshidi L, Nisbet J, Brunet A, et al
    Potentially Psychologically Traumatic Event Exposure Histories of new Royal Canadian Mounted Police Cadets.
    Can J Psychiatry. 2023;68:663-681.
    PubMed     Abstract available
    
    
    August 2023
39. BASTIEN G, McAnulty C, Ledjiar O, Socias ME, et al
    Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
    Can J Psychiatry. 2023;68:572-585.
    PubMed     Abstract available
    
    
    May 2023
40. TOURJMAN SV, Buck G, Jutras-Aswad D, Khullar A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Can J Psychiatry. 2023;68:299-311.
    PubMed     Abstract available
    
    
    April 2023
41. ADHIKARI K, Racine N, Hetherington E, McDonald S, et al
    Women's Mental Health up to Eight Years after Childbirth and Associated Risk Factors: Longitudinal Findings from the All Our Families Cohort in Canada.
    Can J Psychiatry. 2023;68:269-282.
    PubMed     Abstract available
    
    
    
42. WOOD-ROSS C, Tran T, Milanovic M, Jokic R, et al
    Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder.
    Can J Psychiatry. 2023;68:241-248.
    PubMed     Abstract available
    
    
    February 2023
43. ISHRAT HUSAIN M, Rodie DJ, Perivolaris A, Sanches M, et al
    A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial.
    Can J Psychiatry. 2023 Feb 28:7067437231156243. doi: 10.1177/07067437231156243.
    PubMed     Abstract available
    
    
    January 2023
44. GREEN JE, Berk M, Mohebbi M, Loughman A, et al
    Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
    Can J Psychiatry. 2023 Jan 13:7067437221150508. doi: 10.1177/07067437221150508.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.